Aspect Analytics

Aspect Analytics is on a mission to accelerate breakthroughs in drug development by turning rich spatial biology data into precise, actionable insight. The company's core product, the Weave® software platform, provides a governed, multimodal backbone for integrating and analyzing spatial omics and imaging data at single-cell resolution, enabling the study of cellular neighborhoods and tissue architecture. Backed by investors like Capricorn Partners and PMV, and engaged with multiple top 20 pharmaceutical companies, Aspect Analytics is positioned as a leader in the computational foundation for spatial biology.

Weave® is an enterprise-scale spatial biology software platform that uses patented algorithms to fuse and analyze multimodal data (spatial transcriptomics, proteomics, metabolomics, mass spectrometry imaging, histology) at single-cell resolution, enabling the study of cellular neighborhoods and tissue architecture for drug discovery.

Total raised: $4M

Aspect Analytics competes with broad life science informatics clouds (e.g., Revvity Signals), specialized spatial analysis software (e.g., Indica Labs HALO, Akoya informatics), and open-source tools. Its differentiation lies in its patented multimodal data fusion, enterprise-grade design for governed workflows, vendor-neutral interoperability, and deep expertise in mass spectrometry imaging integration.